{
  "ticker": "GPCR",
  "company_name": "Structure Therapeutics Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04558450",
      "title": "Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)",
      "status": "RECRUITING",
      "phase": "NA",
      "condition": "Covid19, Arterial Stiffness, Endothelial Dysfunction, Diastolic Dysfunction",
      "start_date": "2020-09-21",
      "completion_date": "2033-03",
      "enrollment": 0,
      "sponsor": "Assistance Publique - H\u00f4pitaux de Paris"
    },
    {
      "nct_id": "NCT06703021",
      "title": "A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Obesity, Overweight, Chronic Weight Management",
      "start_date": "2024-12-20",
      "completion_date": "2025-12",
      "enrollment": 0,
      "sponsor": "Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics"
    },
    {
      "nct_id": "NCT06693843",
      "title": "A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Obesity, Overweight, or Chronic Weight Management",
      "start_date": "2024-10-17",
      "completion_date": "2026-08",
      "enrollment": 0,
      "sponsor": "Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics"
    },
    {
      "nct_id": "NCT06139055",
      "title": "A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2023-10-02",
      "completion_date": "2024-03",
      "enrollment": 0,
      "sponsor": "Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics"
    },
    {
      "nct_id": "NCT05893043",
      "title": "A Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2023-04-24",
      "completion_date": "2023-06-28",
      "enrollment": 0,
      "sponsor": "Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics"
    },
    {
      "nct_id": "NCT07169942",
      "title": "Aleniglipron Phase 2 Body Composition Study",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Obesity, Overweight, or Chronic Weight Management",
      "start_date": "2025-08-15",
      "completion_date": "2026-09",
      "enrollment": 0,
      "sponsor": "Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics"
    },
    {
      "nct_id": "NCT05762471",
      "title": "Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Overweight or Obesity, Type2 Diabetes Mellitus",
      "start_date": "2023-01-09",
      "completion_date": "2024-04-11",
      "enrollment": 0,
      "sponsor": "Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 7,
    "by_phase": {
      "NA": 1,
      "PHASE2": 3,
      "PHASE1": 2,
      "PHASE1, PHASE2": 1
    },
    "by_status": {
      "RECRUITING": 1,
      "ACTIVE_NOT_RECRUITING": 4,
      "COMPLETED": 2
    },
    "active_trials": 5,
    "completed_trials": 2,
    "conditions": [
      "Covid19, Arterial Stiffness, Endothelial Dysfunction, Diastolic Dysfunction",
      "Healthy Volunteers",
      "Obesity, Overweight, Chronic Weight Management",
      "Obesity, Overweight, or Chronic Weight Management",
      "Overweight or Obesity, Type2 Diabetes Mellitus"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:18:43.523997",
    "search_query": "Structure Therapeutics Inc.",
    "url": "https://clinicaltrials.gov/search?term=Structure+Therapeutics+Inc."
  }
}